[BREAKING] [Exclusive] Application for FDA approval for SK Bioscience GBP510 Vaccine Launched Phase III Clinical Trials for COVID-19 Treatment

1 April Share

[BREAKING] [Exclusive] Application for FDA approval for SK Bioscience GBP510 Vaccine Launched Phase III Clinical Trials for COVID-19 Treatment

［単独］SKバイオサイエンスGBP510ワクチンFDA承認申請、コロナ治療剤の臨床3相に着手

[单独]SK生物科学 GBP510疫苗FDA批准申请,着手进行新冠肺炎治疗剂临床3期

[Только] Заявление на одобрение FDA вакцины SK BioScience GBP510, начало клинической стадии 3 лечения короны.

[단독] SK바이오사이언스 GBP510 백신 FDA승인신청, 코로나치료제 임상3상 착수 [More News]